Biotech Specialty Pharma

Access Pharmaceuticals

2600 Stemmons Freeway, Suite 176
Dallas, TX 75207-2107 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description A biopharmaceutical company that develops products for the care of cancer patients.

Management Jeffrey B. Davis, CEO; Phillip Wise, VP Business Development; David Nowotnik, CSO; Stephen Thompson, CFO; Frank Jacobucci, VP Marketing

Click here for Financial Data
Keywords: synthetic polymer-targeted delivery, vitamin-mediated targeted delivery, vitamin-mediated oral delivery, bioerodible hydrogel technology, nanoparticles and nanoparticle networks, hydrogel particle aggregate technology, Residerm topical delivery, carbohydrate, cancer, ACCP


Updated: Oct. 30, 2015


Access Pharmaceuticals specializes in cancer and supportive care products that are largely based in proprietary nanopolymer technologies. Access has received FDA approval for and markets MuGard......view more

Products / Services

MuGard - FDA-approved for management of oral mucositis; ProLindac - proprietary DACH platinum chemotherapy; Thiarabine - proprietary nucleoside analogue for leukemia/lymphoma; Cobalamin oral drug a......view more

Technology / Differentiation

Polymer Chemistry; drug delivery technology; cobalamin oral drug delivery; cobalamin targeted drug delivery;...view more

Market / Customers

Global pharma market......view more

Competitors / Substitutes / Alternatives

Biovail Corporation, Bristol-Myers Squibb Co., Endo Pharmaceuticals Holdings Inc....view more


Approved, Phase 2, preclinical...view more


    Fatal error: Uncaught Error: Call to undefined function mysql_connect() in /home/onemedpl/public_html/include/counter.php:10 Stack trace: #0 /home/onemedpl/public_html/database/comp_profile_include.php(1079): include() #1 /home/onemedpl/public_html/database/comp_profile.php(87): include('/home/onemedpl/...') #2 {main} thrown in /home/onemedpl/public_html/include/counter.php on line 10